nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—Parkinson's disease	0.525	0.682	CbGaD
Acamprosate—GRIN2B—Parkinson's disease	0.245	0.318	CbGaD
Acamprosate—GRM5—telencephalic ventricle—Parkinson's disease	0.0067	0.0685	CbGeAlD
Acamprosate—GRIN1—telencephalic ventricle—Parkinson's disease	0.00423	0.0432	CbGeAlD
Acamprosate—GRIN2B—telencephalic ventricle—Parkinson's disease	0.00404	0.0412	CbGeAlD
Acamprosate—GRIN2C—nerve—Parkinson's disease	0.00322	0.0329	CbGeAlD
Acamprosate—GRM5—hindbrain—Parkinson's disease	0.00316	0.0323	CbGeAlD
Acamprosate—GRIN2B—nerve—Parkinson's disease	0.00254	0.026	CbGeAlD
Acamprosate—GRIN2C—hindbrain—Parkinson's disease	0.00241	0.0246	CbGeAlD
Acamprosate—GRIN2D—hindbrain—Parkinson's disease	0.00224	0.0229	CbGeAlD
Acamprosate—GRIN2A—nerve—Parkinson's disease	0.00222	0.0227	CbGeAlD
Acamprosate—GRIN1—hindbrain—Parkinson's disease	0.002	0.0204	CbGeAlD
Acamprosate—GRIN2B—hindbrain—Parkinson's disease	0.00191	0.0195	CbGeAlD
Acamprosate—GRM5—brainstem—Parkinson's disease	0.00181	0.0185	CbGeAlD
Acamprosate—GRM5—forebrain—Parkinson's disease	0.00175	0.0179	CbGeAlD
Acamprosate—GRIN2A—hindbrain—Parkinson's disease	0.00167	0.017	CbGeAlD
Acamprosate—SLC36A1—hindbrain—Parkinson's disease	0.00166	0.0169	CbGeAlD
Acamprosate—GRIN2C—brainstem—Parkinson's disease	0.00138	0.0141	CbGeAlD
Acamprosate—GRIN2C—forebrain—Parkinson's disease	0.00133	0.0136	CbGeAlD
Acamprosate—GRIN2D—brainstem—Parkinson's disease	0.00128	0.0131	CbGeAlD
Acamprosate—GRIN2D—forebrain—Parkinson's disease	0.00124	0.0127	CbGeAlD
Acamprosate—GRIN3A—forebrain—Parkinson's disease	0.00117	0.0119	CbGeAlD
Acamprosate—GRM5—midbrain—Parkinson's disease	0.00116	0.0118	CbGeAlD
Acamprosate—GRIN1—brainstem—Parkinson's disease	0.00115	0.0117	CbGeAlD
Acamprosate—GRM5—spinal cord—Parkinson's disease	0.00113	0.0115	CbGeAlD
Acamprosate—GRIN1—forebrain—Parkinson's disease	0.00111	0.0113	CbGeAlD
Acamprosate—GRIN2B—brainstem—Parkinson's disease	0.00109	0.0112	CbGeAlD
Acamprosate—GRIN2B—forebrain—Parkinson's disease	0.00105	0.0108	CbGeAlD
Acamprosate—GRM5—head—Parkinson's disease	0.001	0.0102	CbGeAlD
Acamprosate—GRIN2C—medulla oblongata—Parkinson's disease	0.000964	0.00984	CbGeAlD
Acamprosate—GRIN2A—brainstem—Parkinson's disease	0.000955	0.00975	CbGeAlD
Acamprosate—GRM5—nervous system—Parkinson's disease	0.00095	0.0097	CbGeAlD
Acamprosate—SLC36A1—brainstem—Parkinson's disease	0.000949	0.00969	CbGeAlD
Acamprosate—GABRA1—hindbrain—Parkinson's disease	0.000927	0.00946	CbGeAlD
Acamprosate—GRIN2A—forebrain—Parkinson's disease	0.000922	0.00941	CbGeAlD
Acamprosate—GRM5—central nervous system—Parkinson's disease	0.000915	0.00934	CbGeAlD
Acamprosate—GRIN2D—medulla oblongata—Parkinson's disease	0.000896	0.00915	CbGeAlD
Acamprosate—GRM5—cerebellum—Parkinson's disease	0.000894	0.00913	CbGeAlD
Acamprosate—GRIN2D—spinal cord—Parkinson's disease	0.000799	0.00816	CbGeAlD
Acamprosate—GRIN2C—head—Parkinson's disease	0.000764	0.0078	CbGeAlD
Acamprosate—GRIN1—midbrain—Parkinson's disease	0.00073	0.00745	CbGeAlD
Acamprosate—GRM5—brain—Parkinson's disease	0.000726	0.00742	CbGeAlD
Acamprosate—GRIN2C—nervous system—Parkinson's disease	0.000724	0.00739	CbGeAlD
Acamprosate—GRIN1—spinal cord—Parkinson's disease	0.000712	0.00727	CbGeAlD
Acamprosate—GRIN2D—head—Parkinson's disease	0.00071	0.00725	CbGeAlD
Acamprosate—GRIN2C—central nervous system—Parkinson's disease	0.000697	0.00712	CbGeAlD
Acamprosate—GRIN2C—cerebellum—Parkinson's disease	0.000681	0.00696	CbGeAlD
Acamprosate—GRIN2B—spinal cord—Parkinson's disease	0.000679	0.00694	CbGeAlD
Acamprosate—GRIN2D—nervous system—Parkinson's disease	0.000673	0.00687	CbGeAlD
Acamprosate—GRIN3A—head—Parkinson's disease	0.000668	0.00682	CbGeAlD
Acamprosate—GRIN2A—medulla oblongata—Parkinson's disease	0.000666	0.0068	CbGeAlD
Acamprosate—GRIN2D—central nervous system—Parkinson's disease	0.000648	0.00662	CbGeAlD
Acamprosate—GRIN2D—cerebellum—Parkinson's disease	0.000633	0.00647	CbGeAlD
Acamprosate—GRIN3A—nervous system—Parkinson's disease	0.000633	0.00646	CbGeAlD
Acamprosate—GRIN1—head—Parkinson's disease	0.000633	0.00646	CbGeAlD
Acamprosate—GRIN3A—central nervous system—Parkinson's disease	0.000609	0.00622	CbGeAlD
Acamprosate—GRIN2A—midbrain—Parkinson's disease	0.000609	0.00621	CbGeAlD
Acamprosate—GRIN2B—head—Parkinson's disease	0.000604	0.00616	CbGeAlD
Acamprosate—GRIN1—nervous system—Parkinson's disease	0.0006	0.00613	CbGeAlD
Acamprosate—GRIN2A—spinal cord—Parkinson's disease	0.000594	0.00606	CbGeAlD
Acamprosate—GABRG2—forebrain—Parkinson's disease	0.000581	0.00593	CbGeAlD
Acamprosate—GRIN1—central nervous system—Parkinson's disease	0.000578	0.0059	CbGeAlD
Acamprosate—GRIN2B—nervous system—Parkinson's disease	0.000572	0.00584	CbGeAlD
Acamprosate—GRIN1—cerebellum—Parkinson's disease	0.000565	0.00577	CbGeAlD
Acamprosate—GRIN2C—brain—Parkinson's disease	0.000553	0.00565	CbGeAlD
Acamprosate—GRIN2B—central nervous system—Parkinson's disease	0.000551	0.00563	CbGeAlD
Acamprosate—GRIN2B—cerebellum—Parkinson's disease	0.000539	0.0055	CbGeAlD
Acamprosate—GABRA1—brainstem—Parkinson's disease	0.000531	0.00542	CbGeAlD
Acamprosate—GRIN2A—head—Parkinson's disease	0.000528	0.00539	CbGeAlD
Acamprosate—SLC36A1—head—Parkinson's disease	0.000524	0.00535	CbGeAlD
Acamprosate—GRIN2D—brain—Parkinson's disease	0.000515	0.00525	CbGeAlD
Acamprosate—GABRA1—forebrain—Parkinson's disease	0.000513	0.00523	CbGeAlD
Acamprosate—GRIN2A—nervous system—Parkinson's disease	0.0005	0.00511	CbGeAlD
Acamprosate—SLC36A1—nervous system—Parkinson's disease	0.000497	0.00508	CbGeAlD
Acamprosate—GRIN3A—brain—Parkinson's disease	0.000484	0.00494	CbGeAlD
Acamprosate—GRIN2A—central nervous system—Parkinson's disease	0.000482	0.00492	CbGeAlD
Acamprosate—SLC36A1—central nervous system—Parkinson's disease	0.000479	0.00489	CbGeAlD
Acamprosate—GRIN2A—cerebellum—Parkinson's disease	0.000471	0.00481	CbGeAlD
Acamprosate—SLC36A1—cerebellum—Parkinson's disease	0.000468	0.00478	CbGeAlD
Acamprosate—GRIN1—brain—Parkinson's disease	0.000459	0.00468	CbGeAlD
Acamprosate—GABRB3—forebrain—Parkinson's disease	0.000446	0.00455	CbGeAlD
Acamprosate—GRIN2B—brain—Parkinson's disease	0.000437	0.00447	CbGeAlD
Acamprosate—GABRG2—medulla oblongata—Parkinson's disease	0.000419	0.00428	CbGeAlD
Acamprosate—GABRG2—midbrain—Parkinson's disease	0.000383	0.00391	CbGeAlD
Acamprosate—GRIN2A—brain—Parkinson's disease	0.000382	0.0039	CbGeAlD
Acamprosate—SLC36A1—brain—Parkinson's disease	0.00038	0.00388	CbGeAlD
Acamprosate—GABRG2—spinal cord—Parkinson's disease	0.000374	0.00382	CbGeAlD
Acamprosate—GABRA1—medulla oblongata—Parkinson's disease	0.00037	0.00378	CbGeAlD
Acamprosate—GABRA1—midbrain—Parkinson's disease	0.000339	0.00346	CbGeAlD
Acamprosate—GABRG2—head—Parkinson's disease	0.000332	0.00339	CbGeAlD
Acamprosate—GABRA1—spinal cord—Parkinson's disease	0.00033	0.00337	CbGeAlD
Acamprosate—GABRB3—medulla oblongata—Parkinson's disease	0.000322	0.00329	CbGeAlD
Acamprosate—GABRG2—nervous system—Parkinson's disease	0.000315	0.00322	CbGeAlD
Acamprosate—GABRG2—central nervous system—Parkinson's disease	0.000303	0.0031	CbGeAlD
Acamprosate—GABRG2—cerebellum—Parkinson's disease	0.000297	0.00303	CbGeAlD
Acamprosate—GABRB3—midbrain—Parkinson's disease	0.000294	0.00301	CbGeAlD
Acamprosate—GABRA1—head—Parkinson's disease	0.000294	0.003	CbGeAlD
Acamprosate—GABRB3—spinal cord—Parkinson's disease	0.000287	0.00293	CbGeAlD
Acamprosate—GABRA1—nervous system—Parkinson's disease	0.000278	0.00284	CbGeAlD
Acamprosate—GABRA1—central nervous system—Parkinson's disease	0.000268	0.00274	CbGeAlD
Acamprosate—GABRA1—cerebellum—Parkinson's disease	0.000262	0.00267	CbGeAlD
Acamprosate—GABRB3—head—Parkinson's disease	0.000255	0.00261	CbGeAlD
Acamprosate—GABRB3—nervous system—Parkinson's disease	0.000242	0.00247	CbGeAlD
Acamprosate—GABRG2—brain—Parkinson's disease	0.000241	0.00246	CbGeAlD
Acamprosate—GABRB3—central nervous system—Parkinson's disease	0.000233	0.00238	CbGeAlD
Acamprosate—GABRB3—cerebellum—Parkinson's disease	0.000228	0.00233	CbGeAlD
Acamprosate—GABRA1—brain—Parkinson's disease	0.000213	0.00217	CbGeAlD
Acamprosate—GABRB3—brain—Parkinson's disease	0.000185	0.00189	CbGeAlD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	9.85e-05	0.000743	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—CP—Parkinson's disease	9.83e-05	0.000742	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—DLG1—Parkinson's disease	9.82e-05	0.000741	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	9.75e-05	0.000736	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	9.7e-05	0.000732	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—DLG4—Parkinson's disease	9.67e-05	0.00073	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	9.62e-05	0.000726	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	9.56e-05	0.000721	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PPP1R1B—Parkinson's disease	9.52e-05	0.000718	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	9.5e-05	0.000717	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	9.44e-05	0.000713	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—IL1B—Parkinson's disease	9.4e-05	0.000709	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—EDN1—Parkinson's disease	9.4e-05	0.000709	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—CASP3—Parkinson's disease	9.38e-05	0.000708	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—COMT—Parkinson's disease	9.35e-05	0.000706	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	9.32e-05	0.000703	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—COMT—Parkinson's disease	9.32e-05	0.000703	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—HSPA8—Parkinson's disease	9.29e-05	0.000701	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—MAOA—Parkinson's disease	9.29e-05	0.000701	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—MAOA—Parkinson's disease	9.25e-05	0.000698	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADORA2A—Parkinson's disease	9.04e-05	0.000682	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—NGF—Parkinson's disease	8.99e-05	0.000678	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—GRIK1—Parkinson's disease	8.95e-05	0.000675	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TNF—Parkinson's disease	8.93e-05	0.000674	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—CHRNA4—Parkinson's disease	8.84e-05	0.000667	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—GRIK1—Parkinson's disease	8.79e-05	0.000663	CbGpPWpGaD
Acamprosate—GABRA1—Orphan transporters—CYCS—Parkinson's disease	8.77e-05	0.000662	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NGF—Parkinson's disease	8.76e-05	0.000661	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—DLG4—Parkinson's disease	8.72e-05	0.000658	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	8.71e-05	0.000657	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—COMT—Parkinson's disease	8.7e-05	0.000656	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	8.69e-05	0.000656	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—MAOA—Parkinson's disease	8.63e-05	0.000652	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CHRNA4—Parkinson's disease	8.62e-05	0.00065	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—GDNF—Parkinson's disease	8.59e-05	0.000648	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	8.55e-05	0.000645	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	8.52e-05	0.000643	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—GRIN2B—Parkinson's disease	8.52e-05	0.000643	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	8.51e-05	0.000642	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	8.43e-05	0.000636	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—SLC6A3—Parkinson's disease	8.4e-05	0.000634	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—GDNF—Parkinson's disease	8.37e-05	0.000632	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	8.36e-05	0.000631	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—GRIN2B—Parkinson's disease	8.32e-05	0.000628	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RIT2—Parkinson's disease	8.32e-05	0.000628	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TNF—Parkinson's disease	8.31e-05	0.000627	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	8.25e-05	0.000623	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—HTR2A—Parkinson's disease	8.22e-05	0.00062	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADORA2A—Parkinson's disease	8.21e-05	0.000619	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—IL1B—Parkinson's disease	8.2e-05	0.000619	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—CASP3—Parkinson's disease	8.18e-05	0.000617	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—COMT—Parkinson's disease	8.13e-05	0.000613	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—HSPA8—Parkinson's disease	8.1e-05	0.000612	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	8.07e-05	0.000609	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	8.03e-05	0.000606	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—IL1B—Parkinson's disease	7.99e-05	0.000603	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—CASP3—Parkinson's disease	7.97e-05	0.000602	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	7.97e-05	0.000601	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—COMT—Parkinson's disease	7.92e-05	0.000598	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—HSPA8—Parkinson's disease	7.9e-05	0.000596	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GRK5—Parkinson's disease	7.89e-05	0.000595	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—MAOA—Parkinson's disease	7.87e-05	0.000594	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—HTR1A—Parkinson's disease	7.84e-05	0.000592	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—TAC1—Parkinson's disease	7.72e-05	0.000583	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GRIK1—Parkinson's disease	7.68e-05	0.00058	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	7.67e-05	0.000579	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	7.61e-05	0.000574	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—GRIK2—Parkinson's disease	7.61e-05	0.000574	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—DLG4—Parkinson's disease	7.6e-05	0.000574	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—DRD1—Parkinson's disease	7.57e-05	0.000572	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	7.55e-05	0.00057	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	7.48e-05	0.000564	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	7.47e-05	0.000564	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—GRIK2—Parkinson's disease	7.47e-05	0.000564	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	7.47e-05	0.000563	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	7.47e-05	0.000563	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—GRIN2B—Parkinson's disease	7.43e-05	0.000561	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—DLG4—Parkinson's disease	7.41e-05	0.000559	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—SLC18A2—Parkinson's disease	7.37e-05	0.000556	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—DRD3—Parkinson's disease	7.33e-05	0.000554	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	7.33e-05	0.000553	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	7.33e-05	0.000553	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—SLC6A3—Parkinson's disease	7.32e-05	0.000553	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	7.31e-05	0.000551	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—SLC18A2—Parkinson's disease	7.24e-05	0.000546	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HSPA8—Parkinson's disease	7.19e-05	0.000543	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—SLC6A3—Parkinson's disease	7.14e-05	0.000539	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—COMT—Parkinson's disease	7.14e-05	0.000539	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HTR1A—Parkinson's disease	7.12e-05	0.000537	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—MAOA—Parkinson's disease	7.09e-05	0.000535	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GRM4—Parkinson's disease	7.07e-05	0.000534	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—TAC1—Parkinson's disease	7.01e-05	0.000529	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HSPA8—Parkinson's disease	7.01e-05	0.000529	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.01e-05	0.000529	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	6.98e-05	0.000527	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—DRD1—Parkinson's disease	6.88e-05	0.000519	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	6.85e-05	0.000517	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.85e-05	0.000517	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—Parkinson's disease	6.82e-05	0.000515	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—DLG4—Parkinson's disease	6.75e-05	0.000509	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.73e-05	0.000508	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PENK—Parkinson's disease	6.71e-05	0.000506	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAG—Parkinson's disease	6.71e-05	0.000506	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—BDNF—Parkinson's disease	6.68e-05	0.000504	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—DRD3—Parkinson's disease	6.66e-05	0.000503	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—HTR7—Parkinson's disease	6.63e-05	0.000501	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—DRD2—Parkinson's disease	6.63e-05	0.000501	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TH—Parkinson's disease	6.6e-05	0.000498	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—GRIN2B—Parkinson's disease	6.59e-05	0.000498	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—DLG4—Parkinson's disease	6.58e-05	0.000496	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	6.55e-05	0.000494	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	6.53e-05	0.000493	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GRIK2—Parkinson's disease	6.53e-05	0.000493	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	6.43e-05	0.000485	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	6.41e-05	0.000484	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	6.41e-05	0.000484	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	6.4e-05	0.000483	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SLC18A2—Parkinson's disease	6.32e-05	0.000477	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	6.31e-05	0.000476	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	6.28e-05	0.000474	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—COMT—Parkinson's disease	6.23e-05	0.00047	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADRBK1—Parkinson's disease	6.22e-05	0.000469	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	6.19e-05	0.000467	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MAOA—Parkinson's disease	6.18e-05	0.000467	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDYN—Parkinson's disease	6.13e-05	0.000463	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—COMT—Parkinson's disease	6.07e-05	0.000458	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MAOA—Parkinson's disease	6.03e-05	0.000455	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HTR7—Parkinson's disease	6.02e-05	0.000455	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—DRD2—Parkinson's disease	6.02e-05	0.000455	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	5.99e-05	0.000452	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TNF—Parkinson's disease	5.95e-05	0.000449	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1B—Parkinson's disease	5.95e-05	0.000449	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CASP3—Parkinson's disease	5.93e-05	0.000448	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NGF—Parkinson's disease	5.93e-05	0.000448	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.85e-05	0.000441	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CHRNA4—Parkinson's disease	5.83e-05	0.00044	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—Parkinson's disease	5.8e-05	0.000438	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GFAP—Parkinson's disease	5.77e-05	0.000435	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CHRNA4—Parkinson's disease	5.73e-05	0.000432	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	5.62e-05	0.000424	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.61e-05	0.000424	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	5.58e-05	0.000421	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	5.49e-05	0.000415	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	5.41e-05	0.000409	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	5.38e-05	0.000406	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—ABL1—Parkinson's disease	5.38e-05	0.000406	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—COMT—Parkinson's disease	5.36e-05	0.000405	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HSPA8—Parkinson's disease	5.35e-05	0.000403	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	5.32e-05	0.000402	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—EDN1—Parkinson's disease	5.31e-05	0.000401	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—COMT—Parkinson's disease	5.27e-05	0.000397	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HSPA8—Parkinson's disease	5.25e-05	0.000396	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ABL1—Parkinson's disease	5.24e-05	0.000395	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	5.23e-05	0.000395	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HSPA8—Parkinson's disease	5.13e-05	0.000387	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CASP3—Parkinson's disease	5.06e-05	0.000382	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	5.06e-05	0.000382	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—DLG4—Parkinson's disease	5.02e-05	0.000379	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	5.01e-05	0.000378	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HSPA8—Parkinson's disease	5e-05	0.000377	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF20—Parkinson's disease	5e-05	0.000377	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—CASP3—Parkinson's disease	4.93e-05	0.000372	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—DLG4—Parkinson's disease	4.93e-05	0.000372	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—GRIN2B—Parkinson's disease	4.9e-05	0.00037	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADORA2A—Parkinson's disease	4.85e-05	0.000366	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—SLC6A3—Parkinson's disease	4.83e-05	0.000365	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EDN1—Parkinson's disease	4.82e-05	0.000364	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	4.81e-05	0.000363	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—DLG4—Parkinson's disease	4.81e-05	0.000363	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	4.77e-05	0.00036	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	4.76e-05	0.000359	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	4.75e-05	0.000358	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	4.75e-05	0.000358	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—GRIN2B—Parkinson's disease	4.71e-05	0.000355	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—DLG4—Parkinson's disease	4.69e-05	0.000354	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK8—Parkinson's disease	4.65e-05	0.000351	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—HTR2A—Parkinson's disease	4.65e-05	0.000351	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	4.6e-05	0.000347	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HSPA8—Parkinson's disease	4.59e-05	0.000346	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	4.57e-05	0.000345	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	4.54e-05	0.000343	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK8—Parkinson's disease	4.53e-05	0.000342	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—INSR—Parkinson's disease	4.47e-05	0.000338	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—Parkinson's disease	4.32e-05	0.000326	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—DLG4—Parkinson's disease	4.31e-05	0.000325	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGB—Parkinson's disease	4.23e-05	0.000319	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HTR2A—Parkinson's disease	4.22e-05	0.000318	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	4.21e-05	0.000318	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR1A—Parkinson's disease	4.21e-05	0.000317	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	4.15e-05	0.000313	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TAC1—Parkinson's disease	4.14e-05	0.000313	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—COMT—Parkinson's disease	4.11e-05	0.00031	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MAOA—Parkinson's disease	4.08e-05	0.000308	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD1—Parkinson's disease	4.06e-05	0.000307	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—COMT—Parkinson's disease	4.03e-05	0.000305	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MAOA—Parkinson's disease	4.01e-05	0.000302	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	3.96e-05	0.000299	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD3—Parkinson's disease	3.93e-05	0.000297	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	3.89e-05	0.000294	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ABL1—Parkinson's disease	3.84e-05	0.00029	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ABL1—Parkinson's disease	3.74e-05	0.000282	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRBK1—Parkinson's disease	3.67e-05	0.000277	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CP—Parkinson's disease	3.65e-05	0.000275	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	3.58e-05	0.00027	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD2—Parkinson's disease	3.56e-05	0.000269	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR7—Parkinson's disease	3.56e-05	0.000269	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—COMT—Parkinson's disease	3.53e-05	0.000266	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MAOA—Parkinson's disease	3.5e-05	0.000264	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—Parkinson's disease	3.48e-05	0.000263	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.45e-05	0.000261	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	3.4e-05	0.000257	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	3.34e-05	0.000252	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	3.13e-05	0.000236	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	3.07e-05	0.000232	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF2—Parkinson's disease	2.98e-05	0.000225	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1R—Parkinson's disease	2.88e-05	0.000218	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDN1—Parkinson's disease	2.85e-05	0.000215	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.79e-05	0.00021	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	2.69e-05	0.000203	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	2.69e-05	0.000203	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NGF—Parkinson's disease	2.62e-05	0.000198	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.6e-05	0.000196	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.55e-05	0.000193	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—INS—Parkinson's disease	2.53e-05	0.000191	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.49e-05	0.000188	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR2A—Parkinson's disease	2.49e-05	0.000188	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—INS—Parkinson's disease	2.47e-05	0.000187	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.45e-05	0.000185	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOE—Parkinson's disease	2.32e-05	0.000175	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.23e-05	0.000168	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.17e-05	0.000164	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.14e-05	0.000162	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.13e-05	0.000161	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.08e-05	0.000157	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.04e-05	0.000154	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—INS—Parkinson's disease	1.98e-05	0.000149	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	1.95e-05	0.000148	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.86e-05	0.00014	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.79e-05	0.000135	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	1.58e-05	0.000119	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—Parkinson's disease	1.55e-05	0.000117	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—Parkinson's disease	1.51e-05	0.000114	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—Parkinson's disease	1.47e-05	0.000111	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—Parkinson's disease	1.46e-05	0.00011	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—Parkinson's disease	1.37e-05	0.000104	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK8—Parkinson's disease	1.35e-05	0.000102	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—Parkinson's disease	1.34e-05	0.000101	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—Parkinson's disease	1.11e-05	8.36e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—Parkinson's disease	1.08e-05	8.15e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—Parkinson's disease	8.65e-06	6.53e-05	CbGpPWpGaD
